Becton Dickinson & Co. (BDX) News

Becton Dickinson & Co. (BDX): $252.64

-4.81 (-1.87%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter BDX News Items

BDX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

BDX News Highlights

  • BDX's 30 day story count now stands at 50.
  • Over the past 23 days, the trend for BDX's stories per day has been choppy and unclear. It has oscillated between 1 and 21.
  • BEAT, SA and AMG are the most mentioned tickers in articles about BDX.

Latest BDX News From Around the Web

Below are the latest news stories about Becton Dickinson & Co that investors may wish to consider to help them evaluate BDX as an investment opportunity.

BD to Present at the Cowen 42nd Annual Health Care Conference

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will virtually present at the Cowen 42nd Annual Health Care Conference via webcast. BD's management is scheduled to present on Monday, March 7, 2022 at 9:50 a.m. Eastern Time.

Yahoo | February 24, 2022

Becton Dickinson (BDX) Crossed Above the 20-Day Moving Average: What That Means for Investors

Should investors be excited or worried when a stock crosses above the 20-day simple moving average?

Yahoo | February 24, 2022

If You Invested $1000 in Becton Dickinson 10 Years Ago, This Is How Much You'd Have Now

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

Yahoo | February 24, 2022

BD Appoints Shana Neal as Chief People Officer

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Shana Neal has been appointed chief people officer, effective April 4, 2022.

Yahoo | February 23, 2022

Here's Why You Should Retain BD (BDX) Stock in Your Portfolio

Investors continue to be optimistic about BD (BDX) owing to its slew of regulatory approvals and strategic deals.

Yahoo | February 23, 2022

embecta to Host Virtual Investor Event Ahead of Planned Spinoff from BD

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that embecta, the diabetes care business that is expected to spin off from BD on April 1, 2022, will host a virtual Investor Event on March 7, 2022.

Yahoo | February 23, 2022

Becton Dickinson (NYSE:BDX) shareholders notch a 10% CAGR over 5 years, yet earnings have been shrinking

The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move up...

Yahoo | February 10, 2022

10 Best Dividend Stocks to Buy According to Sculptor Capital

In this article, we will discuss the 10 best dividend stocks to buy according to Sculptor Capital. You can skip our detailed analysis of the hedge fund and its developments, and go directly to read 5 Best Dividend Stocks to Buy According to Sculptor Capital. Sculptor Capital, formerly known as OZ Capital Management, is a […]

Yahoo | February 8, 2022

Diamond Hill Capital Management Buys Becton, Dickinson and Co, SS&C Technologies Holdings ...

Investment company Diamond Hill Capital Management (Current Portfolio) buys Becton, Dickinson and Co, SS&C Technologies Holdings Inc, Texas Instruments Inc, Coterra Energy Inc, Nasdaq Inc, sells Charles Schwab Corp, Gilead Sciences Inc, First Republic Bank, MetLife Inc, Cadence Bank during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Diamond Hill Capital Management.

Yahoo | February 8, 2022

BD Collaborates with ReturnSafe to Help Employers Manage COVID-19 Testing

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration with ReturnSafe, the all-in-one software solution for COVID-19 employee health, safety and compliance, to integrate the BD Veritor™ At-Home COVID-19 Test directly within the ReturnSafe testing management platform.

Yahoo | February 8, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.812 seconds.